29 November 2021
Rymarz Zdort advised the founders of NapoleonCat on securing a strategic investor, RTB House. NapoleonCat is a provider of a comprehensive portfolio of social media marketing tools. The main functi...
28 September 2021
Rymarz Zdort advised Groupe CANAL+ (the “Buyer”) on its acquisition of 70% of the shares in SPI International B.V., the majority shareholder of Kino Polska TV S.A., from Cooperatieve SPI Internationa...
23 September 2021
Rymarz Zdort advised Griffin Real Estate on the conclusion of a joint venture agreement with Kajima Europe involving the financing and development of renewable energy projects located in Poland. As pa...
16 September 2021
Rymarz Zdort provided legal support to PGNiG S.A. ("PGNiG") in connection with the purchase of a controlling stake in Ukrainian company Karpatgazvydobuvannya from Energy Resources of Ukraine Managemen...
26 August 2021
Rymarz Zdort is pleased to announce that in the most recent edition of the IFLR1000 2021 ranking, it has again been recognised as one of the best law firms in Poland for M&A. Rymarz Zdort has been...
13 July 2021
Rymarz Zdort advised Griffin Real Estate on a joint venture agreement with Madison International Realty in connection with their two first investments together in Germany. With Griffin Real Estate’s p...
8 July 2021
Rymarz Zdort advised entities of Energa Capital Group S.A., part of the ORLEN Group, on various aspects of a carve-out of a gas power plant from Elektrownia Ostrołęka sp. z o.o. and in connection with...
7 July 2021
Rymarz Zdort advised Ten Square Games S.A. on its acquisition of 100% of the shares in RORTOS S.r.l. from the company’s current shareholders. Ten Square Games S.A. is a fast-growing mobile game dev...
6 July 2021
Rymarz Zdort advised Wirtualna Polska Media S.A. ("WP") on the purchase of a 3 MW photovoltaic farm in the Lower Silesia region. This is the second such investment by WP, after their first PV farm was...
30 March 2021
Rymarz Zdort advised ExploRNA Therapeutics in the process of an equity investment that involved a subscription for shares in ExploRNA Therapeutics by the fund Black Forest SICAV-SIF (owned by Michał S...